The anatomy of mammalian sweet taste receptors

Proteins: Structure, Function and Bioinformatics

Volumn 85, Issue 2, 2017, Pages 332-341

  Chéron, Jean Baptiste ^a   Golebiowski, Jérôme ^a,b   Antonczak, Serge ^a   Fiorucci, Sébastien ^a  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

^b Daegu Gyeongbuk Institute of Science and Technology   (South Korea)

Author keywords

chemical senses; class C; GPCR; structure function relationships; sweet taste; T1R

Indexed keywords

G PROTEIN COUPLED RECEPTOR; METABOTROPIC RECEPTOR 1; METABOTROPIC RECEPTOR 5; GRM5 PROTEIN, HUMAN; LIGAND; METABOTROPIC GLUTAMATE RECEPTOR TYPE 1; METABOTROPIC RECEPTOR; PROTEIN BINDING; SWEETENING AGENT; TASTE RECEPTORS, TYPE 1;

ARTICLE; BINDING SITE; CRYSTAL STRUCTURE; DISULFIDE BOND; HUMAN; LIGAND BINDING; MAMMAL; MOLECULAR MODEL; NONHUMAN; POINT MUTATION; PREDICTION; PRIORITY JOURNAL; SEQUENCE ALIGNMENT; SITE DIRECTED MUTAGENESIS; STATIC ELECTRICITY; STRUCTURE ACTIVITY RELATION; SURFACE AREA; SWEETNESS; TASTE BUD; AMINO ACID SEQUENCE; CHEMISTRY; GENE EXPRESSION; GENETICS; PHYSIOLOGY; PROTEIN DOMAIN; PROTEIN MULTIMERIZATION; PROTEIN SECONDARY STRUCTURE; STRUCTURAL HOMOLOGY; TASTE;

AMINO ACID SEQUENCE; BINDING SITES; GENE EXPRESSION; HUMANS; LIGANDS; MODELS, MOLECULAR; POINT MUTATION; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, SECONDARY; RECEPTOR, METABOTROPIC GLUTAMATE 5; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, METABOTROPIC GLUTAMATE; SEQUENCE ALIGNMENT; STRUCTURAL HOMOLOGY, PROTEIN; SWEETENING AGENTS; TASTE;

EID: 85010378578     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.25228     Document Type: Article

References (71)

1. Rosenbaum DM, Rasmussen SGF, Kobilka BK. The structure and function of G-protein-coupled receptors. Nature 2009;459:356–363.
2. Katritch V, Cherezov V, Stevens RC. Structure-function of the G protein-coupled receptor superfamily. Annu Rev Pharmacol Toxicol 2013;53:531–556.
3. Kobilka BK, Deupi X. Conformational complexity of G-protein-coupled receptors. Trends Pharmacol Sci 2007;28:397–406.
4. Fredriksson R, Lagerström MC, Lundin L-G, Schiöth HB. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol 2003;63:1256–1272.
5. Isberg V, Mordalski S, Munk C, Rataj K, Harpsøe K, Hauser AS, Vroling B, Bojarski AJ, Vriend G, Gloriam DE. GPCRdb: an information system for G protein-coupled receptors. Nucleic Acids Res 2016;44:D356–D364.
6. Lv X, Liu J, Shi Q, Tan Q, Wu D, Skinner JJ, Walker AL, Zhao L, Gu X, Chen N, Xue L, Si P, Zhang L, Wang Z, Katritch V, Liu Z, Stevens RC. In vitro expression and analysis of the 826 human G protein-coupled receptors. Protein Cell 2016;7:325–337.
7. Zhao GQ, Zhang Y, Hoon MA, Chandrashekar J, Erlenbach I, Ryba NJP, Zuker CS. The receptors for mammalian sweet and umami taste. Cell 2003;115:255–266.
8. Nelson G, Chandrashekar J, Hoon MA, Feng L, Zhao G, Ryba NJP, Zuker CS. An amino-acid taste receptor. Nature 2002;416:199–202.
9. Nelson G, Hoon MA, Chandrashekar J, Zhang Y, Ryba NJP, Zuker CS. Mammalian sweet taste receptors. Cell 2001;106:381–390.
10. Laffitte A, Neiers F, Briand L. Functional roles of the sweet taste receptor in oral and extraoral tissues. Curr Opin Clin Nutr Metab Care 2014;17:379–385.
11. Wellendorph P, Bräuner-Osborne H. Molecular basis for amino acid sensing by family C G-protein-coupled receptors. Br J Pharmacol 2009;156:869–884.
12. Xu H, Staszewski L, Tang H, Adler E, Zoller M, Li X. Different functional roles of T1R subunits in the heteromeric taste receptors. Proc Natl Acad Sci USA 2004;101:14258–14263.
13. Li X, Staszewski L, Xu H, Durick K, Zoller M, Adler E. Human receptors for sweet and umami taste. Proc Natl Acad Sci USA 2002;99:4692–4696.
14. March CA. d, Yu Y, Ni MJ, Adipietro KA, Matsunami H, Ma M, Golebiowski J. Conserved residues control activation of mammalian G protein-coupled odorant receptors. J Am Chem Soc 2015;137:8611–8616.
15. Golebiowski J, Antonczak S, Fiorucci S, Cabrol-Bass D. Mechanistic events underlying odorant binding protein chemoreception. Proteins 2007;67:448–458.
16. Masuda K, Koizumi A, Nakajima K, Tanaka T, Abe K, Misaka T, Ishiguro M. Characterization of the modes of binding between human sweet taste receptor and low-molecular-weight sweet compounds. PLoS One 2012;7:e35380.
17. Maillet EL, Cui M, Jiang P, Mezei M, Hecht E, Quijada J, Margolskee RF, Osman R, Max M. Characterization of the binding site of aspartame in the human sweet taste receptor. Chem Senses 2015;40:577–586.
18. Jiang P, Cui M, Zhao B, Liu Z, Snyder LA, Benard LMJ, Osman R, Margolskee RF, Max M. Lactisole interacts with the transmembrane domains of human T1R3 to inhibit sweet taste. J Biol Chem 2005;280:15238–15246.
19. Jiang P, Cui M, Zhao B, Snyder LA, Benard LMJ, Osman R, Max M, Margolskee RF. Identification of the cyclamate interaction site within the transmembrane domain of the human sweet taste receptor subunit T1R3. J Biol Chem 2005;280:34296–34305.
20. Winnig M, Bufe B, Kratochwil NA, Slack JP, Meyerhof W. The binding site for neohesperidin dihydrochalcone at the human sweet taste receptor. BMC Struct Biol 2007;7:66.
21. Toda Y, Nakagita T, Hayakawa T, Okada S, Narukawa M, Imai H, Ishimaru Y, Misaka T. Two distinct determinants of ligand specificity in T1R1/T1R3 (the umami taste receptor). J Biol Chem 2013;288:36863–36877.
22. Zhang F, Klebansky B, Fine RM, Xu H, Pronin A, Liu H, Tachdjian C, Li X. Molecular mechanism for the umami taste synergism. Proc Natl Acad Sci USA 2008;105:20930–20934.
23. Zhang F, Klebansky B, Fine RM, Liu H, Xu H, Servant G, Zoller M, Tachdjian C, Li X. Molecular mechanism of the sweet taste enhancers. Proc Natl Acad Sci USA 2010;107:4752–4757.
24. Sato T, Shimada Y, Nagasawa N, Nakanishi S, Jingami H. Amino acid mutagenesis of the ligand binding site and the dimer interface of the metabotropic glutamate receptor 1. J Biol Chem 2003;278:4314–4321.
25. Jiang Y, Huang Y, Wong H-C, Zhou Y, Wang X, Yang J, Hall RA, Brown EM, Yang JJ. Elucidation of a novel extracellular calcium-binding site on metabotropic glutamate receptor 1α (mGluR1α) that controls receptor activation. J Biol Chem 2010;285:33463–33474.
26. Kang HJ, Menlove K, Ma J, Wilkins A, Lichtarge O, Wensel TG. Selectivity and evolutionary divergence of metabotropic glutamate receptors for endogenous ligands and G proteins coupled to phospholipase C or TRP channels. J Biol Chem 2014;289:29961–29974.
27. Malherbe P, Knoflach F, Broger C, Ohresser S, Kratzeisen C, Adam G, Stadler H, Kemp J. a, Mutel V. Identification of essential residues involved in the glutamate binding pocket of the group II metabotropic glutamate receptor. Mol Pharmacol 2001;60:944–954.
28. Yao Y, Pattabiraman N, Michne WF, Huang X-P, Hampson DR. Molecular modeling and mutagenesis of the ligand-binding pocket of the mGlu3 subtype of metabotropic glutamate receptor. J Neurochem 2003;86:947–957.
29. Hampson DR, Huang XP, Pekhletski R, Peltekova V, Hornby G, Thomsen C, Thøgersen H. Probing the ligand-binding domain of the mGluR4 subtype of metabotropic glutamate receptor. J Biol Chem 1999;274:33488–33495.
30. Rosemond E, Peltekova V, Naples M, Thøgersen H, Hampson DR. Molecular determinants of high affinity binding to group III metabotropic glutamate receptors. J Biol Chem 2002;277:7333–7340.
31. Hermit MB, Greenwood JR, Bräuner-Osborne H. Mutation-induced quisqualic acid and ibotenic acid affinity at the metabotropic glutamate receptor subtype 4. J Biol Chem 2004;279:34811–34817.
32. Goudet C, Vilar B, Courtiol T, Deltheil T, Bessiron T, Brabet I, Oueslati N, Rigault D, Bertrand H-O, McLean H, Daniel H, Amalric M, Acher F, Pin J-P. A novel selective metabotropic glutamate receptor 4 agonist reveals new possibilities for developing subtype selective ligands with therapeutic potential. Faseb J 2012;26:1682–1693.
33. Galvez T, Parmentier M-L, Joly C, Malitschek B, Kaupmann K, Kuhn R, Bittiger H, Froestl W, Bettler B, Pin J-P. Mutagenesis and modeling of the GABAB receptor extracellular domain support a venus flytrap mechanism for ligand binding. J Biol Chem 1999;274:13362–13369.
34. Mukherjee RS, McBride EW, Beinborn M, Dunlap K, Kopin AS. Point mutations in either subunit of the GABAB receptor confer constitutive activity to the heterodimer. Mol Pharmacol 2006;70:1406–1413.
35. Wu H, Wang C, Gregory KJ, Han GW, Cho HP, Xia Y, Niswender CM, Katritch V, Meiler J, Cherezov V, Conn PJ, Stevens RC. Structure of a class C GPCR metabotropic glutamate receptor 1 bound to an allosteric modulator. Science 2014;344:58–64.
36. Pagano A, Ruegg D, Litschig S, Stoehr N, Stierlin C, Heinrich M, Floersheim P, Prezeau L, Carroll F, Pin J-P, Cambria A, Vranesic I, Flor PJ, Gasparini F, Kuhn R. The non-competitive antagonists 2-methyl-6-(phenylethynyl)pyridine and 7-hydroxyiminocyclopropan[b]chromen-1a-carboxylic acid ethyl ester interact with overlapping binding pockets in the transmembrane region of group I metabotropic glutamate receptors. J Biol Chem 2000;275:33750–33758.
37. Knoflach F, Mutel V, Jolidon S, Kew JN, Malherbe P, Vieira E, Wichmann J, Kemp JA. Positive allosteric modulators of metabotropic glutamate 1 receptor: characterization, mechanism of action, and binding site. Proc Natl Acad Sci USA 2001;98:13402–13407.
38. Malherbe P, Kratochwil N, Knoflach F, Zenner M-T, Kew JNC, Kratzeisen C, Maerki HP, Adam G, Mutel V. Mutational analysis and molecular modeling of the allosteric binding site of a novel, selective, noncompetitive antagonist of the metabotropic glutamate 1 receptor. J Biol Chem 2003;278:8340–8347.
39. Suzuki G, Kimura T, Satow A, Kaneko N, Fukuda J, Hikichi H, Sakai N, Maehara S, Kawagoe-Takaki H, Hata M, Azuma T, Ito S, Kawamoto H, Ohta H. Pharmacological characterization of a new, orally active and potent allosteric metabotropic glutamate receptor 1 antagonist, 4-[1-(2-fluoropyridin-3-yl)−5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide (FTIDC). J Pharmacol Exp Ther 2007;321:1144–1153.
40. Fukuda J, Suzuki G, Kimura T, Nagatomi Y, Ito S, Kawamoto H, Ozaki S, Ohta H. Identification of a novel transmembrane domain involved in the negative modulation of mGluR1 using a newly discovered allosteric mGluR1 antagonist, 3-cyclohexyl-5-fluoro-6-methyl-7-(2-morpholin-4-ylethoxy)−4H-chromen-4-one. Neuropharmacology 2009;57:438–445.
41. Schaffhauser H. Pharmacological characterization and identification of amino acids involved in the positive modulation of metabotropic glutamate receptor subtype 2. Mol Pharmacol 2003;64:798–810.
42. Hemstapat K, Costa HD, Nong Y, Brady AE, Luo Q, Niswender CM, Tamagnan GD, Conn PJ. A novel family of potent negative allosteric modulators of group II metabotropic glutamate receptors. J Pharmacol Exp Ther 2007;322:254–264.
43. Rowe BA, Schaffhauser H, Morales S, Lubbers LS, Bonnefous C, Kamenecka TM, McQuiston J, Daggett LP. Transposition of three amino acids transforms the human metabotropic glutamate receptor (mGluR)−3-positive allosteric modulation site to mGluR2, and additional characterization of the mGluR2-positive allosteric modulation site. J Pharmacol Exp Ther 2008;326:240–251.
44. Molck C, Harpsoe K, Gloriam DE, Clausen RP, Madsen U, Pedersen LO, Jimenez HN, Nielsen SM, Mathiesen JM, Brauner-Osborne H. Pharmacological characterization and modeling of the binding sites of novel 1,3-bis(pyridinylethynyl)benzenes as metabotropic glutamate receptor 5-selective negative allosteric modulators. Mol Pharmacol 2012;82:929–937.
45. Yamashita T, Terakita A, Kai T, Shichida Y. Conformational change of the transmembrane helices II and IV of metabotropic glutamate receptor involved in G protein activation. J Neurochem 2008;106:850–859.
46. Bai M, Quinn S, Trivedi S, Kifor O, Pearce SHS, Pollak MR, Krapcho K, Hebert SC, Brown EM. Expression and characterization of inactivating and activating mutations in the human Ca2+o-sensing receptor. J Biol Chem 1996;271:19537–19545.
47. Jensen AA, Spalding TA, Burstein ES, Sheppard PO, O'Hara PJ, Brann MR, Krogsgaard-Larsen P, Bräuner-Osborne H. Functional importance of the Ala(116)-Pro(136) region in the calcium-sensing receptor. Constitutive activity and inverse agonism in a family C G-protein-coupled receptor. J Biol Chem 2000;275:29547–29555.
48. Rus R, Haag C, Bumke-Vogt C, Bähr V, Mayr B, Möhlig M, Schulze E, Frank-Raue K, Raue F, Schöfl C. Novel inactivating mutations of the calcium-sensing receptor: the calcimimetic NPS R-568 improves signal transduction of mutant receptors. J Clin Endocrinol Metab 2008;93:4797–4803.
49. White E, McKenna J, Cavanaugh A, Breitwieser GE. Pharmacochaperone-mediated rescue of calcium-sensing receptor loss-of-function mutants. Mol Endocrinol 2009;23:1115–1123.
50. Doré AS, Okrasa K, Patel JC, Serrano-vega M, Bennett K, Cooke RM, Errey JC, Jazayeri A, Khan S, Tehan B, Weir M, Wiggin GR, Marshall FH. Structure of class C GPCR metabotropic glutamate receptor 5 transmembrane domain. Nature 2014;511:557–562.
51. Sievers F, Wilm A, Dineen D, Gibson TJ, Karplus K, Li W, Lopez R, McWilliam H, Remmert M, Soding J, Thompson JD, Higgins DG. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol 2014;7:539–539.
52. Pin J-P, Galvez T, Prézeau L. Evolution, structure, and activation mechanism of family 3/C G-protein-coupled receptors. Pharmacol Ther 2003;98:325–354.
53. Šali A, Blundell TL. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 1993;234:779–815.
54. Case DA, Darden TA, Cheatham TE, Simmerling CL, Wang J, Duke RE, Luo R, Walker RC, Zhang W, Merz KM, Roberts B, Hayik S, Roitberg A, Seabra G, Swails J, Götz AW, Kolossváry I, Wong KF, Paesani F, Vanicek J, Wolf RM, Liu J, Wu X, Brozell SR, Steinbrecher T, Gohlke H, Cai Q, Ye X, Wang J, Hsieh M-J, Cui G, Roe DR, Mathews DH, Seetin MG, Salomon-Ferrer R, Sagui C, Babin V, Luchko T, Gusarov S, Kovalenko A, Kollman PA. AMBER 12. San Francisco: University of California; 2012.
55. Guilloux VL, Schmidtke P, Tuffery P. Fpocket: an open source platform for ligand pocket detection. BMC Bioinformatics 2009;10:168.
56. Morikawa K, Kunishima N, Shimada Y, Tsuji Y, Sato T, Yamamoto M, Kumasaka T, Nakanishi S, Jingami H, Morikawa K. Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor. Nature 2000;407:971–977.
57. Muto T, Tsuchiya D, Morikawa K, Jingami H. Structures of the extracellular regions of the group II/III metabotropic glutamate receptors. Proc Natl Acad Sci USA 2007;104:3759–3764.
58. Tsuchiya D, Kunishima N, Kamiya N, Jingami H, Morikawa K. Structural views of the ligand-binding cores of a metabotropic glutamate receptor complexed with an antagonist and both glutamate and Gd3+. Proc Natl Acad Sci USA 2002;99:2660–2665.
59. Monn JA, Valli MJ, Massey SM, Hao J, Reinhard MR, Bures MG, Heinz BA, Wang X, Carter JH, Getman BG, Stephenson GA, Herin M, Catlow JT, Swanson S, Johnson BG, McKinzie DL, Henry SS. Synthesis and pharmacological characterization of 4-substituted-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylates: identification of new potent and selective metabotropic glutamate 2/3 receptor agonists. J Med Chem 2013;56:4442–4455.
60. DuBois GE, Prakash I. Non-Caloric Sweeteners, Sweetness Modulators, and Sweetener Enhancers. Annu Rev Food Sci Technol 2012;3:353–380.
61. Behrens M, Meyerhof W, Hellfritsch C, Hofmann T. Sweet and umami taste: natural products, their chemosensory targets, and beyond. Angew Chem Int Ed Engl 2011;50:2220–2242.
62. Temussi PA. New insights into the characteristics of sweet and bitter taste receptors. Inte Rev Cell Mol Biol 2011;291:191–226.
63. Acher FC, Selvam C, Pin J-P, Goudet C, Bertrand H-O. A critical pocket close to the glutamate binding site of mGlu receptors opens new possibilities for agonist design. Neuropharmacology 2011;60:102–107.
64. Goudet C, Gaven F, Kniazeff J, Vol C, Liu J, Cohen-Gonsaud M, Acher F, Prézeau L, Pin JP. Heptahelical domain of metabotropic glutamate receptor 5 behaves like rhodopsin-like receptors. Proc Natl Acad Sci USA 2004;101:378–383.
65. DuBois GE. Molecular mechanism of sweetness sensation. Physiol Behav 2016;164:453–463.
66. Trzaskowski B, Latek D, Yuan S, Ghoshdastider U, Debinski A, Filipek S. Action of molecular switches in GPCRs–theoretical and experimental studies. Curr Med Chem 2012;19:1090–1109.
67. Deupi X, Standfuss J. Structural insights into agonist-induced activation of G-protein-coupled receptors. Curr Opin Struct Biol 2011;21:541–551.
68. Palczewski K. Crystal Structure of Rhodopsin: A G Protein-Coupled Receptor. Science 2000;289:739–745.
69. Standfuss J, Edwards PC, D'Antona A, Fransen M, Xie G, Oprian DD, Schertler GFX. The structural basis of agonist-induced activation in constitutively active rhodopsin. Nature 2011;471:656–660.
70. Xue L, Rovira X, Scholler P, Zhao H, Liu J, Pin J-P, Rondard P. Major ligand-induced rearrangement of the heptahelical domain interface in a GPCR dimer. Nat Chem Biol 2015;11:134–140.
71. Bachmanov AA. Genetic Architecture of Sweet Taste. In: Weerasinghe DK, DuBois GE, editors. Sweetness and Sweeteners. Washington, DC: American Chemical Society; 2008. pp 18–47.